Second Generation of Antiepileptic Drugs and Oxidative Stress

Area of Science:

• Neuroscience
• Pharmacology
• Oxidative Stress Research

Background:

• Epilepsy is a chronic neurological disorder characterized by recurrent seizures, often involving excessive oxidant formation and neuronal death.
• Oxidative stress plays a significant role in epileptogenesis and other neurological conditions.
• Understanding the impact of newer antiepileptic drugs (AEDs) on oxidative stress is crucial for patient management.

Purpose of the Study:

• To review the current knowledge on the relationship between newer antiepileptic drugs (AEDs) and oxidative stress.
• To investigate the effects of GABA-ergic and other AEDs on neuronal oxidation markers.

Main Methods:

• Comprehensive literature review of studies examining newer antiepileptic drugs (AEDs) and their effects on oxidative stress.
• Analysis of drug mechanisms, including GABA-ergic transmission enhancement and other pathways.
• Examination of dose-dependent effects and neuroprotective/neurodegenerative outcomes.

Main Results:

• Many newer AEDs, particularly those enhancing GABA-ergic transmission (e.g., vigabatrin, tiagabine, gabapentin, topiramate), appear to reduce markers of neuronal oxidation.
• Lamotrigine and levetiracetam also show potential in reducing oxidative stress, though levetiracetam's effects can be complex.
• GABA-enhancing drugs, when applied to healthy tissue, can increase oxidative stress markers in a dose-dependent manner.
• Diazepam exhibits a U-shaped dose-dependent neuroprotective effect, with high concentrations leading to neurodegeneration.

Conclusions:

• Newer AEDs that enhance GABA-ergic neurotransmission may offer neuroprotection by reducing oxidative stress.
• However, similar to diazepam, high doses of these AEDs could potentially induce neurodegeneration and exacerbate oxidative stress.
• Careful dose management is essential when using these medications to balance therapeutic benefits with potential risks.